Cancers | Free Full-Text | TP53 Combined Phenotype Score Is Associated with the Clinical Outcome of TP53-Mutated Myelodysplastic Syndromes
Cancers | Free Full-Text | Influence of TP53 Mutation on Survival of Diffuse Large B-Cell Lymphoma in the CAR T-Cell Era
Life and Death Decision-Making by p53 and Implications for Cancer Immunotherapy: Trends in Cancer
Frequency of p53 mutations in human cancers. (A) Schematic picture... | Download Scientific Diagram
TP53 alterations of hormone-naïve prostate cancer in the Chinese population | Prostate Cancer and Prostatic Diseases
LRP1B or TP53 mutations are associated with higher tumor mutational burden and worse survival in hepatocellular carcinoma
Targeting a neoantigen derived from a common TP53 mutation | Science
Prevalence of germline TP53 mutation among early onset middle eastern breast cancer patients | Hereditary Cancer in Clinical Practice | Full Text
Landscape of somatic single nucleotide variants and indels in colorectal cancer and impact on survival | Nature Communications
Germline TP53 mutations undergo copy number gain years prior to tumor diagnosis | Nature Communications
IJMS | Free Full-Text | The Therapeutic Potential of the Restoration of the p53 Protein Family Members in the EGFR-Mutated Lung Cancer
Mutant p53 Drives Cancer Metastasis via RCP-Mediated Hsp90α Secretion - ScienceDirect
p53 inactivating mutations. (A) Frequency of p53 mutations among tumors... | Download Scientific Diagram
Frontiers | Promising New Tools for Targeting p53 Mutant Cancers: Humoral and Cell-Based Immunotherapies
TP53 Mutation as Potential Negative Predictor for Response of Anti-CTLA-4 Therapy in Metastatic Melanoma - eBioMedicine
High prevalence of TP53 loss and whole-genome doubling in early-onset colorectal cancer | Experimental & Molecular Medicine
Mutant p53 elicits context-dependent pro-tumorigenic phenotypes | Oncogene
IJMS | Free Full-Text | Do Mutations Turn p53 into an Oncogene?
IJMS | Free Full-Text | Primary Founder Mutations in the PRKDC Gene Increase Tumor Mutation Load in Colorectal Cancer
p53 Is the Most Frequently Mutated Gene in Cancer, but Can We Target It?
TP53/BRAF mutation as an aid in predicting response to immune-checkpoint inhibitor across multiple cancer types | Aging
Frontiers | Association Analyses of TP53 Mutation With Prognosis, Tumor Mutational Burden, and Immunological Features in Acute Myeloid Leukemia
The function of a heterozygous p53 mutation in a Li-Fraumeni syndrome patient | PLOS ONE
p53 Is the Most Frequently Mutated Gene in Cancer, but Can We Target It?
